new medicines

rare-1280x720

Major change for rare disease treatments on way, signals MHRA

A new paper from the MHRA sets out UK regulator's intention to overhaul its rulebook for rare disease therapies.

04 Nov 2025 , 1 Min Article

eczema

Nemolizumab approved for prurigo nodularis and atopic dermatitis

Nemolizumab (Nemluvio, Galderma) has been approved by the MHRA for the treatment of two skins conditions.

18 Feb 2025 , 1 Min Article

2018 pill_s.jpg

Key 2018 practice developments

This CPD module provides an overview of some of the major developments in pharmacy practice during 2018.

14 Dec 2018 , 900 Min Module

2017 review_s.jpg

Key practice developments of 2017

This CPD module provides an overview of key practice developments of 2017.

13 Dec 2017 , 900 Min Module

Change privacy settings